Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors. Gallois C, Landi M, Taieb J, Sroussi M, et al. Clin Cancer Res 2023 Jul 13:CCR-22-3964. doi: 10.1158/1078-0432.CCR-22-3964.

Read + Share

Amedeo Smart

Independent Medical Education

Gallois C, Landi M, Taieb J, Sroussi M, et al. Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors. Clin Cancer Res 2023 Jul 13:CCR-22-3964. doi: 10.1158/1078-0432.CCR-22-3964.
PMID: 37439810